Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Which camera do you believe is great for first-time clients? ! - 2Figure out How to Establish a long term connection with Your Handshake
- 3The 15 Most Rousing TED Chats on Self-awareness
- 4Make your choice for the music application with the most amicable connection point!
- 5The Best Business visionaries Under 30
- 5 High Limit Outer Hard Drives For Information Stockpiling
- Wisconsin judge sends Slender Man attacker back to mental health institution after group home escape
- Striking American and European television Projects: A Survey
- Best Wellness Tracker Keep You On target
- Hezbollah claims right to respond to killing of top commander
- 10 Delectable Specialty Mixed drinks
- Chinese astronauts’ return to Earth delayed over fears spaceship damaged by debris
- Explainer-What has happened to the damaged spacecraft at China's space station?
- I’m a doctor. Here are 10 science-backed tips to help you get healthier.
